Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+268.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
50.2x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.49 | +202.6% |
| 2023 | 0.16 | +3505.3% |
| 2022 | 0.00 | -54.0% |
| 2021 | 0.01 | +278.1% |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | +100.0% |
| 2017 | -0.35 | - |